naratriptan
(AWEZYKMQFAUBTD-UHFFFAOYSA-N)
Structure
- SMILES
- CNS(=O)(=O)CCc1ccc2c(c1)c(c[nH]2)C1CCN(CC1)C.Cl
- Molecular Formula:
- C17H26ClN3O2S
- Molecular Weight:
- 371.925
- Log P:
- 4.2804
- Hydrogen Bond Acceptor:
- 4
- Hydrogen Bond Donor:
- 3
- TPSA:
- 73.58
- CAS Number(s):
- 143388-64-1
Synonym(s)
1.
naratriptan
2.
1H-indole-5-ethanesulfonamide, N-methyl-3-(1-methyl-4-piperidinyl)-, monohydrochloride
3.
Amerge
4.
Colatan
5.
GR 85548A
6.
N-methyl-3-(1-methyl-4-piperidinyl)-1H-indole-5-ethanesulfonamide
7.
N-methyl-3-(1-methyl-4-piperidyl)indole-5-ethanesulfonamide monohydrochloride
8.
Naramig
9.
naratriptan hydrochloride
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Drug ineffective | FAERS: 26 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 2 | Nausea | FAERS: 12 | US FAERS | |
| 3 | Vomiting | FAERS: 8 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 4 | Chest Pain | FAERS: 6 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 5 | Myocardial Infarction | FAERS: 6 | US FAERS | |
| 6 | Drug abuse | FAERS: 5 | US FAERS | |
| 7 | Headache | FAERS: 5 | US FAERS | |
| 8 | Overdose | FAERS: 5 | US FAERS | |
| 9 | Drug Dependence | FAERS: 4 | US FAERS | |
| 10 | Malaise | FAERS: 4 | US FAERS | |
| 11 | Pharmaceutical product complaint | FAERS: 4 | US FAERS | |
| 12 | Abdominal Pain | FAERS: 3 | US FAERS | |
| 13 | Arthralgia | FAERS: 3 | US FAERS | |
| 14 | Asthenia | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 15 | Brain natriuretic peptide increased | FAERS: 3 | US FAERS | |
| 16 | Cardiac Arrest | FAERS: 3 | US FAERS | |
| 17 | Depressed Level of Consciousness | FAERS: 3 | US FAERS | |
| 18 | Drug exposure during pregnancy | FAERS: 3 | US FAERS | |
| 19 | Product quality issue | FAERS: 3 | US FAERS | |
| 20 | Pulmonary Embolism | FAERS: 3 | US FAERS | |
| 21 | Somnolence | FAERS: 3 | US FAERS | |
| 22 | Troponin T increased | FAERS: 3 | US FAERS | |
| 23 | Vasospasm | FAERS: 3 | US FAERS | |
| 24 | Accidental overdose | FAERS: 2 | US FAERS | |
| 25 | Bilirubinuria | FAERS: 2 | US FAERS | |
| 26 | Bradycardia | FAERS: 2 | US FAERS | |
| 27 | Dizziness | FAERS: 2 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 28 | Drug administration error | FAERS: 2 | US FAERS | |
| 29 | Erythema | FAERS: 2 | US FAERS | |
| 30 | Feeling abnormal | FAERS: 2 | US FAERS | |
| 31 | HELLP Syndrome | FAERS: 2 | US FAERS | |
| 32 | Hypotension | FAERS: 2 | US FAERS | |
| 33 | Medication Error | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 34 | Neck Pain | FAERS: 2 | US FAERS | |
| 35 | Necrosis | FAERS: 2 | US FAERS | |
| 36 | Normal delivery | FAERS: 2 | US FAERS | |
| 37 | Pain | FAERS: 2 | US FAERS | |
| 38 | Palpitations | FAERS: 2 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 39 | Pharyngolaryngeal Pain | FAERS: 2 | US FAERS | |
| 40 | Phlebitis | FAERS: 2 | US FAERS | |
| 41 | Skin necrosis | FAERS: 2 | US FAERS | |
| 42 | Transaminases increased | FAERS: 2 | US FAERS | |
| 43 | Accidental drug intake by child | FAERS: 1 | US FAERS | |
| 44 | Acne | FAERS: 1 | US FAERS | |
| 45 | Acute Coronary Syndrome | FAERS: 1 | US FAERS | |
| 46 | Adverse event | FAERS: 1 | US FAERS | |
| 47 | Amnesia | FAERS: 1 | US FAERS | |
| 48 | Angina Pectoris | FAERS: 1 | US FAERS | |
| 49 | Anxiety | FAERS: 1 | US FAERS | |
| 50 | Aphasia | FAERS: 1 | US FAERS | |
| 51 | Atrial Fibrillation | FAERS: 1 | US FAERS | |
| 52 | Back Pain | FAERS: 1 | US FAERS | |
| 53 | Blindness | FAERS: 1 | US FAERS | |
| 54 | Blood creatinine increased | FAERS: 1 | US FAERS | |
| 55 | Chest discomfort | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 56 | Choking | FAERS: 1 | US FAERS | |
| 57 | Chorioretinitis | FAERS: 1 | US FAERS | |
| 58 | Creatinine renal clearance decreased | FAERS: 1 | US FAERS | |
| 59 | Deafness | FAERS: 1 | US FAERS | |
| 60 | Dependence | FAERS: 1 | US FAERS | |
| 61 | Drug abuser | FAERS: 1 | US FAERS | |
| 62 | Drug dose omission | FAERS: 1 | US FAERS | |
| 63 | Drug effect incomplete | FAERS: 1 | US FAERS | |
| 64 | Drug ineffective for unapproved indication | FAERS: 1 | US FAERS | |
| 65 | Elevated mood | FAERS: 1 | US FAERS | |
| 66 | Emotional distress | FAERS: 1 | US FAERS | |
| 67 | Exposure via semen | FAERS: 1 | US FAERS | |
| 68 | Extravasation | FAERS: 1 | US FAERS | |
| 69 | Food Allergy | FAERS: 1 | US FAERS | |
| 70 | Glaucoma | FAERS: 1 | US FAERS | |
| 71 | Glomerular vascular disorder | FAERS: 1 | US FAERS | |
| 72 | Gluten sensitivity | FAERS: 1 | US FAERS | |
| 73 | Hemiparesis | FAERS: 1 | US FAERS | |
| 74 | Hemiplegia | FAERS: 1 | US FAERS | |
| 75 | Hepatitis | FAERS: 1 | US FAERS | |
| 76 | Hypomania | FAERS: 1 | US FAERS | |
| 77 | Inability to afford medication | FAERS: 1 | US FAERS | |
| 78 | Large intestine perforation | FAERS: 1 | US FAERS | |
| 79 | Laryngospasm | FAERS: 1 | US FAERS | |
| 80 | Memory impairment | FAERS: 1 | US FAERS | |
| 81 | Metrorrhagia | FAERS: 1 | US FAERS | |
| 82 | Myalgia | FAERS: 1 | US FAERS | |
| 83 | Nasal inflammation | FAERS: 1 | US FAERS | |
| 84 | Optic Neuritis | FAERS: 1 | US FAERS | |
| 85 | Oropharyngeal pain | FAERS: 1 | US FAERS | |
| 86 | Pericardial effusion | FAERS: 1 | US FAERS | |
| 87 | Phalangeal agenesis | FAERS: 1 | US FAERS | |
| 88 | Pneumonia | FAERS: 1 | US FAERS | |
| 89 | Prescribed underdose | FAERS: 1 | US FAERS | |
| 90 | Product substitution issue | FAERS: 1 | US FAERS | |
| 91 | Product use issue | FAERS: 1 | US FAERS | |
| 92 | Pulmonary Hypertension | FAERS: 1 | US FAERS | |
| 93 | Rhabdomyolysis | FAERS: 1 | US FAERS | |
| 94 | Scoliosis surgery | FAERS: 1 | US FAERS | |
| 95 | Serotonin Syndrome | FAERS: 1 | US FAERS | |
| 96 | Skin tightness | FAERS: 1 | US FAERS | |
| 97 | Supraventricular tachycardia | FAERS: 1 | US FAERS | |
| 98 | Swelling | FAERS: 1 | US FAERS | |
| 99 | Syncope | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 100 | Temperature intolerance | FAERS: 1 | US FAERS | |
| 101 | Thalamic infarction | FAERS: 1 | US FAERS | |
| 102 | Therapeutic response unexpected | FAERS: 1 | US FAERS | |
| 103 | Thrombosis | FAERS: 1 | US FAERS | |
| 104 | Tinnitus | FAERS: 1 | US FAERS | |
| 105 | Ulcer | FAERS: 1 | US FAERS | |
| 106 | Unevaluable event | FAERS: 1 | US FAERS | |
| 107 | Urticaria | FAERS: 1 | US FAERS | |
| 108 | VIIth nerve paralysis | FAERS: 1 | US FAERS | |
| 109 | Vitreous floaters | FAERS: 1 | US FAERS | |
| 110 | jaundice | FAERS: 1 | US FAERS | |
| 111 | Anembryonic gestation | Canada Vigilance: 1 | Canada Vigilance | |
| 112 | Cyanosis | Canada Vigilance: 1 | Canada Vigilance | |
| 113 | Muscle Spasticity | Canada Vigilance: 1 | Canada Vigilance | |
| 114 | Tachycardia | Canada Vigilance: 1 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120237
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.